Hashmi, S. K. Basics of hematopoietic cell transplantation for primary care physicians and internists. Prim. Care Clin. Off. Pract. 43, 693–701 (2016).
Kehl, D. et al. Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential. npj Regen. Med. 4, 8 (2019).
Thanaskody, K. et al. MSCs vs. iPSCs: potential in therapeutic applications. Front. Cell Dev. Biol. https://doi.org/10.3389/fcell.2022.1005926 (2022).
İnandıklıoğlu, N. & Akkoc, T. in Stem Cell-based Therapeutic Approaches in Disease. Cell Biology and Translational Medicine, Vol. 9 (ed. Turksen, K.) 5–12 (Springer, 2021).
Fernández-Muñoz, B. et al. Retrieval of germinal zone neural stem cells from the cerebrospinal fluid of premature infants with intraventricular hemorrhage. Stem Cell Transl. Med. 9, 1085–1101 (2020).
Marotta, M. et al. Isolation, characterization, and differentiation of multipotent neural progenitor cells from human cerebrospinal fluid in fetal cystic myelomeningocele. Stem Cell Res. 22, 33–42 (2017).
Cai, M. et al. Standards of induced pluripotent stem cells derived clinical-grade neural stem cells preparation and quality control (2021 China version). J. Neurorestoratol. 9, 13–30 (2021).
Barak, M. et al. Human iPSC-derived neural models for studying Alzheimer’s disease: from neural stem cells to cerebral organoids. Stem Cell Rev. Rep. 18, 792–820 (2022).
Shi, Yanhong, Inoue, Haruhiso & Yamanaka, S. Induced pluripotent stem cell technology: a decade of progress. Nat. Rev. Drug. Discov. 176, 115–130 (2017).
Fujikawa, T. et al. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am. J. Pathol. 166, 1781–1791 (2005).
Lee, A. S. et al. Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8, 2608–2612 (2009).
Dagur, P. K. & McCoy, J. P. Collection, storage, and preparation of human blood cells. Curr. Protoc. Cytom. 2015, 5.1.1–5.1.16 (2015).
Connelly-Smith, L. S. & Linenberger, M. L. Therapeutic apheresis for patients with cancer. Cancer Control. 22, 60–78 (2015).
Bieback, K., Schallmoser, K., Klüter, H. & Strunk, D. Clinical protocols for the isolation and expansion of mesenchymal stromal cells. Transfus. Med. Hemother. 35, 286–294 (2008).
Rodríguez-Fuentes, D. E. et al. Mesenchymal stem cells current clinical applications: a systematic review. Arch. Med. Res. 52, 93–101 (2021).
Xu, C., Police, S., Rao, N. & Carpenter, M. K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. 91, 501–508 (2002).
Laflamme, M. A. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015–1024 (2007).
Wada, T. et al. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS ONE 4, e6722 (2009).
Liu, W. et al. Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies. Proteomics 11, 3556–3564 (2011).
Levine, B. L., Miskin, J., Wonnacott, K. & Keir, C. Global manufacturing of CAR T cell therapy. Mol. Ther. Methods Clin. Dev. 4, 92–101 (2017).
Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317 (2006).
Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep. 4, 3594 (2014).
Hagbard, L. et al. Developing defined substrates for stem cell culture and differentiation. Phil. Trans. R. Soc. B 373, 20170230 (2018).
Schmidt, S., Lilienkampf, A. & Bradley, M. New substrates for stem cell control. Phil. Trans. R. Soc. B 373, 20170223 (2018).
Hwang, N. S., Varghese, S. & Elisseeff, J. Controlled differentiation of stem cells. Adv. Drug Deliv. Rev. 60, 199–214 (2008).
Gerardo, H. et al. Soft culture substrates favor stem-like cellular phenotype and facilitate reprogramming of human mesenchymal stem/stromal cells (hMSCs) through mechanotransduction. Sci. Rep. 9, 9086 (2019).
Navarrete, R. O. et al. Substrate stiffness controls osteoblastic and chondrocytic differentiation of mesenchymal stem cells without exogenous stimuli. PLoS ONE 12, 1–18 (2017).
Zhang, T. et al. Regulating osteogenesis and adipogenesis in adipose-derived stem cells by controlling underlying substrate stiffness. J. Cell. Physiol. 233, 3418–3428 (2018).
Wang, B., Tu, X., Wei, J., Wang, L. & Chen, Y. Substrate elasticity dependent colony formation and cardiac differentiation of human induced pluripotent stem cells. Biofabrication 11, 015005 (2019).
Gungordu, H. I. et al. Effect of mechanical loading and substrate elasticity on the osteogenic and adipogenic differentiation of mesenchymal stem cells. J. Tissue Eng. Regen. Med. 13, 2279–2290 (2019).
Engler, A. J., Sen, S., Sweeney, H. L. & Discher, D. E. Matrix elasticity directs stem cell lineage specification. Cell 126, 677–689 (2006).
Zhang, Y. et al. The effects of pore architecture in silk fibroin scaffolds on the growth and differentiation of mesenchymal stem cells expressing BMP7. Acta Biomater. 6, 3021–3028 (2010).
Taqvi, S. & Roy, K. Influence of scaffold physical properties and stromal cell coculture on hematopoietic differentiation of mouse embryonic stem cells. Biomaterials 27, 6024–6031 (2006).
Haugh, M. G. et al. Investigating the interplay between substrate stiffness and ligand chemistry in directing mesenchymal stem cell differentiation within 3D macro-porous substrates. Biomaterials 171, 23–33 (2018).
Moosazadeh Moghaddam, M. et al. Engineered substrates with imprinted cell-like topographies induce direct differentiation of adipose-derived mesenchymal stem cells into Schwann cells. Artif. Cells Nanomed. Biotechnol. 47, 1022–1035 (2019).
Adil, M. M. et al. Efficient generation of hPSC-derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform. Sci. Rep. 7, 40573 (2017).
Kothapalli, C. R. & Kamm, R. D. 3D matrix microenvironment for targeted differentiation of embryonic stem cells into neural and glial lineages. Biomaterials 34, 5995–6007 (2013).
Xing, F. et al. Regulation and directing stem cell fate by tissue engineering functional microenvironments: scaffold physical and chemical cues. Stem Cells Int. 2019, 2180925 (2019).
Shibata, S. et al. Cell-type-specific adhesiveness and proliferation propensity on laminin isoforms enable purification of iPSC-derived corneal epithelium. Stem Cell Rep. 14, 663–676 (2020).
Jiang, S., Müller, M. & Schönherr, H. Propagation and purification of human induced pluripotent stem cells with selective homopolymer release surfaces. Angew. Chem. Int. Ed. 58, 10563–10566 (2019).
Yeh, C. C. et al. Data of continuous harvest of stem cells via partial detachment from thermoresponsive nanobrush surfaces. Data Brief 6, 603–608 (2016).
Tohyama, S. et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12, 127–137 (2013).
Hemmi, N. et al. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. Stem Cell Trans. Med. 3, 1473–1483 (2014).
Bohaciakova, D. et al. A scalable solution for isolating human multipotent clinical-grade neural stem cells from ES precursors. Stem Cell Res. Ther. 10, 83 (2019).
Shinozawa, T., Furukawa, H., Sato, E. & Takami, K. A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation. J. Biomol. Screen. 17, 683–691 (2012).
Regha, K. et al. Customized strategies for high-yield purification of retinal pigment epithelial cells differentiated from different stem cell sources. Sci. Rep. 12, 15563 (2022).
Teramura, T. et al. Laser-assisted cell removing (LACR) technology contributes to the purification process of the undifferentiated cell fraction during pluripotent stem cell culture. Biochem. Biophys. Res. Commun. 503, 3114–3120 (2018).
Kim, M., Namkung, Y., Hyun, D. & Hong, S. Prediction of stem cell state using cell image-based deep learning. Adv. Intell. Syst. https://doi.org/10.1002/aisy.202370031 (2023).
Waisman, A. et al. Deep learning neural networks highly predict very early onset of pluripotent stem cell differentiation. Stem Cell Rep. 12, 845–859 (2019).
Datta, S. et al. Laser capture microdissection: big data from small samples. Histol. Histopathol. 30, 1255–1269 (2015).
Fiedler, S., Shirley, S. G., Schnelle, T. & Fuhr, G. Dielectrophoretic sorting of particles and cells in a microsystem. Anal. Chem. 70, 1909–1915 (1998).
Zhang, Y. et al. From passive to active sorting in microfluidics: a review. Rev. Adv. Mater. Sci. 60, 313–324 (2021).
Ding, L. et al. Scaling up stem cell production: harnessing the potential of microfluidic devices. Biotechnol. Adv. 69, 108271 (2023).
Wu, H. W., Hsu, R. C., Lin, C. C., Hwang, S. M. & Lee, G. B. An integrated microfluidic system for isolation, counting, and sorting of hematopoietic stem cells. Biomicrofluidics 4, 024112 (2010).
Hatch, A., Pesko, D. M. & Murthy, S. K. Tag-free microfluidic separation of cells against multiple markers. Anal. Chem. 84, 4618–4621 (2012).
Sheng, W. et al. Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. Anal. Chem. 84, 4199–4206 (2012).
Reinholt, S. J. & Craighead, H. G. Microfluidic device for aptamer-based cancer cell capture and genetic mutation detection. Anal. Chem. 90, 2601–2608 (2018).
Lecault, V. et al. High-throughput analysis of single hematopoietic stem cell proliferation in microfluidic cell culture arrays. Nat. Methods 8, 581–589 (2011).
Schirhagl, R., Fuereder, I., Hall, E. W., Medeiros, B. C. & Zare, R. N. Microfluidic purification and analysis of hematopoietic stem cells from bone marrow. Lab Chip 11, 3130–3135 (2011).
Singh, A. et al. Adhesive signature-based, label-free isolation of human pluripotent stem cells. ASME 2012. Summer Bioeng. Conf. 10, 313–314 (2012).
Li, X. et al. On chip purification of hiPSC-derived cardiomyocytes using a fishnet-like microstructure. Biofabrication 8, 035017 (2016).
Jabart, E. et al. A microfluidic method for the selection of undifferentiated human embryonic stem cells and in situ analysis. Microfluid. Nanofluidics 18, 955–966 (2015).
Wang, X. et al. Enhanced cell sorting and manipulation with combined optical tweezer and microfluidic chip technologies. Lab Chip 11, 3656–3662 (2011).
Ajanth, P., Sudeepthi, A. & Sen, A. K. Microfluidics technology for label-free isolation of circulating tumor cells. J. Inst. Eng. Ser. C 101, 1051–1071 (2020).
Gao, Z. & Li, Y. Enhancing single-cell biology through advanced AI-powered microfluidics. Biomicrofluidics 17, 051301 (2023).
Bacon, K., Lavoie, A., Rao, B. M., Daniele, M. & Menegatti, S. Past, present, and future of affinity-based cell separation technologies. Acta Biomater. 112, 29–51 (2020).
Kummrow, A. et al. Quantitative assessment of cell viability based on flow cytometry and microscopy. Cytometry A 83 A, 197–204 (2013).
Cao, X. et al. Differentiation and functional comparison of monocytes and macrophages from hiPSCs with peripheral blood derivatives. Stem Cell Rep. 12, 1282–1297 (2019).
Pan, J. & Wan, J. Methodological comparison of FACS and MACS isolation of enriched microglia and astrocytes from mouse brain. J. Immunol. Methods 486, 112834 (2020).
Miki, K. et al. Efficient detection and purification of cell populations using synthetic MicroRNA switches. Cell Stem Cell 16, 699–711 (2015).
Fernandez, A. G. et al. High-throughput fluorescence-based isolation of live C. elegans larvae. Nat. Protoc. 7, 1502–1510 (2012).
Longmire, T. A. et al. Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell 10, 398–411 (2012).
Fulwyler, M. J. Electronic separation of biological cells by volume. Science 150, 910–911 (1965).
Sommer, U. et al. High-sensitivity flow cytometric assays: considerations for design control and analytical validation for identification of rare events. Cytometry B Clin. Cytom. 100, 42–51 (2021).
Curtis, M. G., Walker, B. & Denny, T. N. Flow cytometric methods for prenatal and neonatal diagnosis. J. Immunol. Methods 363, 198–209 (2011).
Dubois, N. C. et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat. Biotechnol. 29, 1011–1018 (2011).
Pontén, A. et al. FACS-based isolation, propagation and characterization of mouse embryonic cardiomyocytes based on VCAM-1 surface marker expression. PLoS ONE 8, e82403 (2013).
Hattori, F. et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat. Methods 7, 61–66 (2010).
Ben-David, U., Nudel, N. & Benvenisty, N. Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Nat. Commun. 4, 1992 (2013).
Sutermaster, B. A. & Darling, E. M. Considerations for high-yield, high-throughput cell enrichment: fluorescence versus magnetic sorting. Sci. Rep. 9, 227 (2019).
Vemuri, M. C., Chase, L. G. & Rao, M. S. Mesenchymal stem cell assays and applications. Methods Mol. Biol. 698, 3–8 (2011).
Ray, K., Gupta, S. M., Bala, M., Muralidhar, S. & Kumar, J. CD4/CD8 lymphocyte counts in healthy, HIV-positive individuals & AIDS patients. Indian J. Med. Res. 124, 319–330 (2006).
Buranapraditkun, S. et al. Cost savings by reagent reduction in flow cytometry-based CD4+ T cell counts: an approach to improve accessibility for HIV management. Asian Pac. J. Allergy Immunol. 25, 83–89 (2007).
Bomberger, C. et al. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood 91, 2588–2600 (1998).
Tricot, G. et al. Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma. Blood 91, 4489–4495 (1998).
Müller, A. M. S. et al. Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells. Biol. Blood Marrow Transplant. 18, 125–133 (2012).
Michallet, M. et al. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp. Hematol. 28, 858–870 (2000).
Vose, J. M. et al. Transplantation of highly purified CD34+Thy-I+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin’s lymphoma. Biol. Blood Marrow Transplant. 7, 680–687 (2001).
Kikuchi, T. et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model. Nature 548, 592–596 (2017).
Doi, D., Gaiser, J., Grummitt, D., Knöbel, S. & Takahashi, J. GMP-compliant microchip based cell sorting of iPSCs-derived dopaminergic progenitors [Poster]. https://static.miltenyibiotec.com/asset/150655405641/document_5d7p4psfsh46jbrc45eu500f52?content-disposition=inline (2019).
Molday, R. S., Yen, S. P. S. & Rembaum, A. Application of magnetic microspheres in labelling and separation of cells. Nature 268, 437–438 (1977).
Miltenyi, S., Müller, W., Weichel, W. & Radbruch, A. High gradient magnetic cell separation with MACS. Cytometry 11, 231–238 (1990).
Moore, D. K. et al. Isolation of B-cells using Miltenyi MACS bead isolation kits. PLoS ONE 14, e0213832 (2019).
Generali, M. et al. Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells. Acta Biomater. 97, 333–343 (2019).
Park, S. S. et al. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Investig. Ophthalmol. Vis. Sci. 56, 81–89 (2015).
Meier-Ruge, W. et al. The laser in the Lowry technique for microdissection of freeze-dried tissue slices. Histochem. J. 8, 387–401 (1976).
Niyaz, Y. et al. in Microarrays in Clinical Diagnostics (eds Joos, T. O. & Fortina, P.) 1–24 (Humana, 2005).
Haqqani, A. S. et al. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT‐nanoLC‐MS/MS. FASEB J. 19, 1809–1821 (2005).
Mojsilovic-Petrovic, J., Nesic, M., Pen, A., Zhang, W. & Stanimirovic, D. Development of rapid staining protocols for laser-capture microdissection of brain vessels from human and rat coupled to gene expression analyses. J. Neurosci. Methods 133, 39–48 (2004).
Johnsen, A. R., Hausner, M., Schnell, A. & Wuertz, S. Evaluation of fluorescently labeled lectins for noninvasive localization of extracellular polymeric substances in Sphingomonas biofilms. Appl. Environ. Microbiol. 66, 3487 (2000).
Murray, G. I. (ed.) Laser Capture Microdissection. Methods in Molecular Biology, Vol. 1723 (Humana, 2018).
Hosokawa, M. & Morikawa, K. Augmentation of antitumor immune responses by the antitumor antibiotic bleomycin. Jpn. J. Cancer Chemother. 11, 2700–2708 (1984).
Eberle, F. C. et al. Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J. Mol. Diagnostics 12, 394–401 (2010).
Buckanovich, R. J. et al. Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment. Cancer Biol. Ther. 5, 635–642 (2006).
Terstegge, S. et al. Laser-assisted selection and passaging of human pluripotent stem cell colonies. J. Biotechnol. 143, 224–230 (2009).
Wysocki, L. J. & Sato, V. L. Panning for lymphocytes: a method for cell selection. Proc. Natl Acad. Sci. USA 75, 2844–2848 (1978).
Mage, M. G., McHugh, L. L. & Rothstein, T. L. Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J. Immunol. Methods 15, 47–56 (1977).
Dittel, B. N. Depletion of specific cell populations by complement depletion. J. Vis. Exp. https://doi.org/10.3791/1487 (2010).
Kacherovsky, N. et al. Traceless aptamer-mediated isolation of CD8+ T cells for chimeric antigen receptor T-cell therapy. Nat. Biomed. Eng. 3, 783–795 (2019).
Gray, B. P., Requena, M. D., Nichols, M. D. & Sullenger, B. A. Aptamers as reversible sorting ligands for preparation of cells in their native state. Cell Chem. Biol. 27, 232–244.e7 (2020).
Gawande, B. N. et al. Selection of DNA aptamers with two modified bases. Proc. Natl Acad. Sci. USA 114, 2898–2903 (2017).
Tyagi, S. & Kramer, F. R. Molecular beacon probes that fluoresce on hybridization. Nat. Biotechnol. 14, 303–308 (1996).
Huang, K. & Martí, A. A. Recent trends in molecular beacon design and applications. Anal. Bioanal. Chem. 402, 3091–3102 (2012).
Ban, K. et al. Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA. Circulation 128, 1897–1909 (2013).
Klug, M. G., Soonpaa, M. H., Koh, G. Y. & Field, L. J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98, 216–224 (1996).
Hacein-Bey-Abina, S. et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132–3142 (2008).
Anzalone, A. V. et al. Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nat. Biotechnol. 40, 731–740 (2022).
Nakanishi, M. & Otsu, M. Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine. Curr. Gene Ther. 12, 410–416 (2012).
Nakanishi, H. & Saito, H. in Mammalian Cell Engineering: Methods and Protocols (ed. Kojima, R.) 73–86 (Springer, 2021).
Hirosawa, M. et al. Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switch. Nucleic Acids Res 45, e118 (2017).
Parr, C. J. C. et al. MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells. Sci. Rep. 6, 32532 (2016).
Sunohara, T. et al. MicroRNA-based separation of cortico-fugal projection neuron-like cells derived from embryonic stem cells. Front. Neurosci. https://doi.org/10.3389/fnins.2019.01141 (2019).
Tsujisaka, Y. et al. Purification of human iPSC-derived cells at large scale using microRNA switch and magnetic-activated cell sorting. Stem Cell Rep. 17, 1772–1785 (2022).
Endo, K., Hayashi, K. & Saito, H. High-resolution identification and separation of living cell types by multiple microRNA-responsive synthetic mRNAs. Sci. Rep. 6, 21991 (2016).
Endo, K., Hayashi, K. & Saito, H. Numerical operations in living cells by programmable RNA devices. Sci. Adv. https://doi.org/10.1126/sciadv.aax0835 (2019).
Nakanishi, H. et al. Monitoring and visualizing microRNA dynamics during live cell differentiation using microRNA-responsive non-viral reporter vectors. Biomaterials 128, 121–135 (2017).
Fujita, Y. et al. A versatile and robust cell purification system with an RNA-only circuit composed of microRNA-responsive ON and OFF switches. Sci. Adv. 8, eabj1793 (2022).
DiAndreth, B., Wauford, N., Hu, E., Palacios, S. & Weiss, R. PERSIST platform provides programmable RNA regulation using CRISPR endoRNases. Nat. Commun. 13, 2582 (2022).
Qian, Y. et al. Programmable RNA sensing for cell monitoring and manipulation. Nature 610, 713–721 (2022).
Jiang, K. et al. Programmable eukaryotic protein synthesis with RNA sensors by harnessing ADAR. Nat. Biotechnol. 41, 698–707 (2022).
Kaseniit, K. E. et al. Modular, programmable RNA sensing using ADAR editing in living cells. Nat. Biotechnol. 41, 482–487 (2022).
Pardi, M. L., Wu, J., Kawasaki, S. & Saito, H. Synthetic RNA-based post-transcriptional expression control methods and genetic circuits. Adv. Drug. Deliv. Rev. 184, 114196 (2022).
Chastagnier, L., Marquette, C. & Petiot, E. In situ transient transfection of 3D cell cultures and tissues, a promising tool for tissue engineering and gene therapy. Biotechnol. Adv. 68, 108211 (2023).
Xue, L. et al. Rational design of bisphosphonate lipid-like materials for mRNA delivery to the bone microenvironment. J. Am. Chem. Soc. 144, 9926–9937 (2022).
Ma, F. et al. Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection. Sci. Adv. 6, eabb4429 (2020).
Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).
Kameda, S., Ohno, H. & Saito, H. Synthetic circular RNA switches and circuits that control protein expression in mammalian cells. Nucleic Acids Res. 51, E24 (2023).
& Yoshioka, N. et al. Efficient generation of human iPS cells by a synthetic self-replicative RNA. Cell Stem Cell 13, 246–254 (2012).
Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008).
Yoshihara, M., Hayashizaki, Y. & Murakawa, Y. Genomic instability of iPSCs: challenges towards their clinical applications. Stem Cell Rev. Rep. 13, 7–16 (2017).
Ji, J. et al. Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cell 30, 435–440 (2012).
Oikonomopoulos, A., Kitani, T. & Wu, J. C. Pluripotent stem cell-derived cardiomyocytes as a platform for cell therapy applications: progress and hurdles for clinical translation. Mol. Ther. 26, 1624–1634 (2018).
Chehelgerdi, M. et al. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy. Mol. Cancer 22, 189 (2023).
Nelson, J. et al. Impact of mRNA chemistry and manufacturing process on innate immune activation. Sci. Adv. 6, eaaz6893 (2020).
Mulroney, T. E. et al. N 1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting. Nature 625, 189–194 (2024).
Takahashi, H. et al. BCG vaccinations drive epigenetic changes to the human T cell receptor: restored expression in type 1 diabetes. Sci. Adv. 8, eabq7240 (2022).
Yamaguchi, Y. et al. Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells. JCI Insight 7, e163347 (2022).
Kim, J. Y., Nam, Y., Rim, Y. A. & Ju, J. H. Review of the current trends in clinical trials involving induced pluripotent stem cells. Stem Cell Rev. Rep. 18, 142–154 (2022).
Mandai, M. et al. Autologous induced stem-cell–derived retinal cells for macular degeneration. N. Engl. J. Med. 376, 1038–1046 (2017).
Ikeda, M. I. O. et al. High-purity isolation for genotyping rare cancer cells from blood using a microfluidic chip cell sorter. Anticancer Res. 42, 407–417 (2022).
Menasché, P. et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur. Heart J. 36, 2011–2017 (2015).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s44222-024-00220-2